Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetes

Author： Jendle J.   Torffvit O.   Ridderstråle M.   Lammert M.   Ericsson Å.   Bøgelund M.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.26, Iss.4, 2010-04, pp. : 917-923

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel treatments for type 2 diabetes

By Searle Alan  

British Journal of General Practice, Vol. 61, Iss. 586, 2011-05 ,pp. : 325-326

Royal College of General Practitioners

Access to resources Recommend Favorite

New treatments for type 2 diabetes

By Cascales Laura  

Medical Writing, Vol. 21, Iss. 4, 2012-12 ,pp. : 279-283

Maney Publishing

Access to resources Recommend Favorite

Novel treatments for type 2 diabetes

By Seewoodhary Jason   Bain Stephen C  

British Journal of General Practice, Vol. 61, Iss. 582, 2011-01 ,pp. : 5-6

Royal College of General Practitioners

Access to resources Recommend Favorite

Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain

By Tunis Sandra L.   Willis William D.   Foos Volker  

Current Medical Research and Opinion, Vol. 26, Iss. 1, 2010-01 ,pp. : 163-175

Informa Healthcare

Access to resources Recommend Favorite

Self-monitoring of blood glucose (SMBG) for type 2 diabetes patients treated with oral anti-diabetes drugs and with a recent history of monitoring: cost-effectiveness in the US

By Tunis Sandra L.   Minshall Michael E.  

Current Medical Research and Opinion, Vol. 26, Iss. 1, 2010-01 ,pp. : 151-162

Informa Healthcare

Access to resources Recommend Favorite